Skip to main content
Psychopharmacology Bulletin › All Volumes & Issues › VOL 52 No. 3 › Possible Lurasidone-Associated Dose-Dependent...
COMPLICATED CASE HISTORY

Possible Lurasidone-Associated Dose-Dependent QTc Prolongation in First-Episode Psychosis

Ahmed Naguy, Suliman Al-Khadhari, Saxby Pridmore
Psychopharmacology Bulletin 52(3): 68-71, 2022/06/27; https://doi.org/10.64719/pb.4445

Abstract

This case is one of the earliest to report on lurasidone-related QTc prolongation in a dose-dependent fashion in CAP population at therapeutic doses. Although these reports remain scarce, it behoves prescribers to be vigilant and mindful of these unusual but serious side effects especially in setting of cumulative risks.

Keywords

adolescent, FEP, lurasidone, QTc

Access This Article

Choose an access option below to view the full article.

Subscriber Access

If you or your institution has a subscription, log in to access this article.

Log In
Not yet subscribed? View subscription options

Purchase Article

Buy single-article access with a one-time purchase.

$30.00
Add to Cart

How to Cite

Ahmed Naguy, Suliman Al-Khadhari, Saxby Pridmore. Possible Lurasidone-Associated Dose-Dependent QTc Prolongation in First-Episode Psychosis. Psychopharmacology Bulletin. 2022/06/27; 52(3):68-71. https://doi.org/10.64719/pb.4445